Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
about
Effects of PTH on osteocyte functionSkeletal secretion of FGF-23 regulates phosphate and vitamin D metabolismBone disease in pediatric chronic kidney diseaseFibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus MetabolismRole of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney diseaseCardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular DiseaseDeletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- miceFunctional diversity of fibroblast growth factors in bone formationRelationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing ParathyroidectomyFibroblast growth factor 23 enhances renal klotho abundance1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6Fibroblast growth factor (Fgf) 23 gene transcription depends on actin cytoskeleton reorganization.Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolismOsteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone.The use of fibroblast growth factor 23 testing in patients with kidney disease.Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.FGF23 protein expression in coronary arteries is associated with impaired kidney function.Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis.The human response to acute enteral and parenteral phosphate loadsRenal phosphate wasting in the absence of adenylyl cyclase 6Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy.Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.GNAS Spectrum of Disorders.Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.Arterial calcification and bone physiology: role of the bone-vascular axis.Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse boneUpdate on fibroblast growth factor 23 in chronic kidney disease.FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.Osteocytes and Skeletal PathophysiologyA Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1RRenal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide.Ablation of the Stimulatory G Protein α-Subunit in Renal Proximal Tubules Leads to Parathyroid Hormone-Resistance With Increased Renal Cyp24a1 mRNA Abundance and Reduced Serum 1,25-Dihydroxyvitamin D.Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo.Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional linksFibroblast growth factor 23 and bone mineralisation.Systemic Control of Bone Homeostasis by FGF23 Signaling.
P2860
Q24631082-40CC733C-EC9F-49D6-AF51-082CD3C8B26FQ26852624-D73BB34D-0A16-48BD-81B7-4344F6FE04ADQ26864102-3F58FF03-D7A4-473F-8608-6E289923C09DQ26866263-35E490E0-6633-4A7C-8536-2D4AE97C1614Q27000415-09F07567-A8FC-402C-9BCF-8835FB07AB14Q27024043-C196427A-FA39-47BD-A21A-50FE09A9CD30Q27333726-A724FFCC-B1FF-4908-9259-9697ED16ED91Q28086929-65C90FFB-5117-4DF1-9553-0FD92BCD0B1DQ28546638-6EB39635-2709-40BE-B6C1-810984BD7868Q28570342-42BAB7D0-146A-485B-8F72-AFE1E5C5A23EQ28572351-50891248-C5D9-4B6B-9FD1-9B418A3846A7Q30315564-6827AF71-D205-4BA6-BBB6-8BD8689227EFQ30544587-61639880-F4EF-416E-BC09-8E953D3214B7Q30619950-DCDF0088-BAE1-4706-B3F4-B636430AFEF6Q33835743-40D9B419-34B2-47CA-BC3A-E71369C0E96CQ33901231-C64B1C88-AAA3-4E9F-84B2-A47F60C34554Q33985430-7D43DA6F-1C10-4C12-B9ED-C24663F675C7Q34069793-5983718D-81D2-4B1E-8D57-E09A328973D3Q34568785-AB7D058F-DC74-4C9F-A64D-06B3CF0105D4Q34568797-7A874639-2335-431F-BA6B-803D2C3E80DAQ35067500-6EB9FD11-7E91-4072-A1C5-CBED0F256286Q35096719-814C497D-55F8-4B61-B07D-6CA9A0497B15Q35182281-93ADE2A1-8F40-4DA3-B413-1E61C7825751Q35563016-EE3108D1-96BA-444C-9DC7-86A1D04BA9ACQ35682152-7E0AA86A-79F7-49C6-8AE1-444BCBB6D20FQ35729489-52160E27-4F2A-4F6E-B9BE-FEEE6527272BQ36177303-831A5A1C-65B7-4C11-9B97-98EAF7D2A108Q36208896-CBE3A6F6-E6AE-4C6A-8189-392DBE9319C5Q36210285-7809A8D1-98CD-42E9-B116-D55037A9B1C6Q36260612-61A9FA01-5A42-4246-A992-AAD1616B21D1Q36357606-D31D39C9-20F2-457B-B531-33A791A90238Q36381365-798997A7-99D9-4F77-8F1D-7282D2858047Q36385342-E071895C-6997-4A28-9ECB-21D170FA98BAQ36473726-DC518486-240D-4942-9235-6F8911BFDA9AQ36492263-21C95605-0E96-468D-AF7E-B23CD4B88232Q36521099-A2DEEEB8-D4E5-46B9-9659-68D5A745A8DFQ36592828-918B2A8A-360E-440D-B282-E9922B21C5A0Q36648170-F808ED67-5098-4E13-9758-9EBA3282F407Q36756061-F1C48D05-1390-4AEC-802E-3AD9B5B0488CQ36843642-E35668CD-4592-4BEC-82ED-3021F2C77307
P2860
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Parathyroid hormone receptor s ...... factor-23 in vitro and in vivo
@ast
Parathyroid hormone receptor s ...... factor-23 in vitro and in vivo
@en
type
label
Parathyroid hormone receptor s ...... factor-23 in vitro and in vivo
@ast
Parathyroid hormone receptor s ...... factor-23 in vitro and in vivo
@en
prefLabel
Parathyroid hormone receptor s ...... factor-23 in vitro and in vivo
@ast
Parathyroid hormone receptor s ...... factor-23 in vitro and in vivo
@en
P2093
P2860
P1433
P1476
Parathyroid hormone receptor s ...... factor-23 in vitro and in vivo
@en
P2093
Emily Farrow
Kenneth E White
Lilian I Plotkin
Nicoletta Bivi
Virginia Lezcano
Yumie Rhee
P2860
P304
P356
10.1016/J.BONE.2011.06.025
P577
2011-06-25T00:00:00Z